Personal Statement
Dr. Masoud Isanejad is a researcher specialising in molecular and systems epidemiology, with expertise spanning clinical nutrition, precision nutrition, cardiometabolic health, ageing, and biomarker science. His work brings together epidemiological data and original mechanistic clinical studies to investigate complex interactions between nutrition, metabolism, cardiovascular health, skeletal muscle, and age-related disease.

He has developed an interdisciplinary research profile combining population-based epidemiology with molecular profiling, multi-omics, metabotyping, and clinical phenotyping. His expertise includes the investigation and validation of potential biomarkers associated with common age-related and cardiometabolic conditions, including heart failure and diabetes, as well as sarcopenia, frailty, and functional decline. He is particularly interested in understanding how molecular signatures reflect disease processes and whether they can be modified through nutritional and lifestyle interventions.

His research experience spans epidemiological analyses, biomarker discovery, mechanistic clinical research, deep phenotyping, and intervention studies. This work has enabled him to connect molecular evidence with clinically relevant outcomes and to translate complex biological findings into practical approaches for disease prevention and management. Building on this foundation, Dr. Isanejad’s research is increasingly focused on precision nutrition and personalised approaches to healthy ageing. He investigates how individual biological and metabolic characteristics can inform nutritional strategies aimed at improving cardiometabolic health, preserving muscle function, and maintaining physiological resilience across the ageing process.

Research Overview
Dr. Masoud Isanejad is a researcher in molecular and systems epidemiology, investigating biological pathways that contribute to common age-related and cardiometabolic diseases and their consequences for health and function. His work integrates epidemiological data with original mechanistic clinical studies, combining population-level evidence with detailed molecular and phenotypic characterisation to understand interactions between heart failure, diabetes, muscle health, metabolism, inflammation, and ageing.

His research applies metabolomics, lipidomics, metabotyping, and biomarker profiling to identify molecular signatures associated with disease susceptibility, progression, and functional decline. By integrating these data with clinical and epidemiological outcomes, he investigates potential biomarkers for common age-related diseases and explores their capacity to improve early risk identification, disease stratification, and monitoring of physiological changes. An important aspect of this work is determining whether potentially informative biomarkers are modifiable through nutritional and lifestyle interventions, providing a bridge between molecular epidemiology and clinical translation.

Within this framework, muscle health is considered an important component of overall physiological resilience. His research examines how metabolic dysfunction, chronic disease, inflammation, and nutritional factors contribute to sarcopenia and frailty, and how these processes interact with conditions such as heart failure and diabetes. This integrated approach seeks to identify shared mechanisms linking systemic disease with changes in muscle function and physical capacity.

His research extends into precision nutrition, using molecular, metabolic, and phenotypic information to understand individual variation in nutritional requirements and responses to dietary intervention. A particular interest is the diet–gut microbiome–metabolism–muscle–heart axis, including how dietary exposures and microbiome-derived metabolites influence host metabolism, inflammation, cardiovascular health, and skeletal muscle.

Through longitudinal epidemiological studies, mechanistic clinical research, deep phenotyping, and intervention trials, Dr. Isanejad aims to translate molecular findings into personalised and scalable nutritional strategies. His research ultimately seeks to identify modifiable biological pathways and develop precision approaches that can support prevention and management of heart failure, diabetes, sarcopenia, frailty, and other age-related conditions, while promoting healthier ageing and functional independence.